Navigation Links
Impotence Drug Cialis Might Have Other Sexual Benefits: Study
Date:1/30/2013

WEDNESDAY, Jan. 30 (HealthDay News) -- Cialis, the erectile dysfunction medication known to help men get ready for sex, may also help encourage ejaculation and orgasm, a new study suggests.

"There are many men who have, at most, very mild problems achieving an erection but who cannot easily ejaculate. Our study shows Cialis works very well for these men with problems ejaculating," lead researcher Dr. Darius Paduch, director of Sexual Health and Medicine at Weill Cornell Medical College in New York City, said in a college news release.

In the study, which was funded by Cialis' maker, Eli Lilly and Company, Paduch's team analyzed data from 17 clinical trials involving men with erectile dysfunction and/or trouble ejaculating or achieving orgasm. The trials included almost 3,600 men averaging about 55 years of age. The men typically took Cialis for 12 weeks, at varying doses.

As reported in the February issue of the British Journal of Urology International, Paduch and his colleagues found that about 70 percent of the men who used Cialis (tadalafil) for sexual activity were able to ejaculate most of the time and to reach orgasm, compared with 30 percent of men who did not take the drug.

The improved ability to ejaculate and achieve orgasm was seen despite the severity of a man's erectile dysfunction, according to the researchers.

Paduch noted that up to 18 percent of men have a normal erection but don't ejaculate, or take a long time to do so. The problem is more common in older men, but affects those of all ages.

"Many of my patients are young men who want to have children and so they want to solve their issues with ejaculation," said Paduch, who is also a urologist and male sexual medicine specialist at NewYork-Presbyterian/Weill Cornell Medical Center. "We don't know why this occurs. Every internist faces this problem in his male patients and has no options to offer. Our study shows Cialis may help
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Severe Gum Disease May Be Linked to Impotence
2. Severe Gum Disease, Impotence May Be Linked
3. Tripp, D.O, F.A.C.O.O.G., Adelstein, D.O, F.A.C.O.O.G., MacFarlane, M.D., F.A.C.O.G., Vardo, D.O, F.A.C.O.G., & Abisla, A.N.P., Receive InTone Specialist Certification
4. Surgical Supply Specialist Nouvelle Inc. Announces Products for Care of Traumatic Burns and Scars
5. Minimally Invasive and Robotic Treatment for Pelvic Organ Prolapse (POP) Now Available from the Specialists at Women’s Excellence in Bladder Control in Clarkston, MI
6. Two RMACT Fertility Specialists Named ‘Best Doctors in America’
7. Benefit Specialists Deems International Health Insurance a Must-Have for Spring Vacations
8. Women and Infants Maternal-Fetal Medicine specialist selected for editorial team
9. Apex Mold Specialists Earns Esteemed 2012 Angie’s List Super Service Award
10. Best Wheelchair Lifts for Your Porch or Deck: Tips from Aging in Place Specialist, Gordon Raney
11. A Media Representative for Dr. Castro Announces New Updates on the Dental Implants Specialist in Rancho Cucamonga's Website with Information on Digital X-Rays
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Impotence Drug Cialis Might Have Other Sexual Benefits: Study
(Date:3/4/2015)... Information Innovators Inc . (Triple-i) is honored ... the company as Chief Technology Officer. Mr. Dvorak will ... company, including customer-centric strategies and initiatives, and promoting continuous ... as a technology executive and visionary. Prior to joining ... including oversight of enterprise data management, analytic software development, ...
(Date:3/4/2015)... 2015 The Alliance for Regenerative ... its upcoming fifth annual Advanced Therapies Summit next ... event this year will feature five expert-led interactive ... the field’s leading companies and organizations. , ... and clinical researchers from the advanced therapies community ...
(Date:3/4/2015)... March 04, 2015 The Conrad N. ... a total of $6.9 million, which will help 151,000 ... and Burkina Faso. , The programs cover three years ... will focus on fixing water points in disrepair, addressing ... local people to maintain water points and ensuring safe ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Nike Swim ... and staff whose mission is to stimulate a love ... “Nike Swim Camps provide campers the opportunity to train ... nation,” says Paul Merrion, Vice President of US Sports ... enabling each swimmer to build confidence and improve their ...
(Date:3/4/2015)... Nitrosigine®, a patented complex of bonded arginine ... products, is hosting the Nitrosigine Pump Challenge at the ... at The Arnold Sports Festival in Columbus, Ohio. The ... 8, 2015. , Nitrosigine is a patented ingredient ... notification status; now affirmed as GRAS.^ It has been ...
Breaking Medicine News(10 mins):Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 3Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4Health News:US Sports Camps and Nike Swim Camps Announce the 2015 Swim Camps Lineup 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3
... and Accelerates Physician TrainingGREAT BARRINGTON, Mass., March 17 ... surgical training models, is improving how ENT physicians ... Trainer. This innovative technology was recently designed ... on their new FinESS(TM) Sinus Treatment, a less-invasive ...
... 17 Innophos Holdings, Inc. (Nasdaq: ... declared a dividend of $0.17 per share of common stock. ... stockholders of record as of the close of business on ... , Innophos Holdings, Inc., the parent company of Innophos, Inc. ...
... the past few years, a number of anti-cancer drugs ... key molecules of tumor cells. Among these is an ... that is found in large amounts on the surface ... molecule, called epidermal growth factor receptor, or EGF-R for ...
... for Drug Evaluation and Research (CDER), industry, and academia will convene ... (April 26-29; Arlington, VA) to discuss statistical methodologies and quantitative ... , ... Horsham, PA (Vocus) March 17, 2009 -- ...
... John Hancock Life Insurance Company led the industry ... to recent industry year-end surveys of LTC insurers.* In ... across all of its LTC insurance businesses, giving the ... marks John Hancock,s second year in a row as ...
... What can you buy with a dollar anymore? ... and treatment for those who cannot afford to battle breast ... Brandon Mendelson and the 1 in 8 Foundation are challenging ... $1 and provide care and complete support for women and ...
Cached Medicine News:Health News:Chamberlain Group Surgical Training Model Facilitates New Treatment for Chronic Rhinosinusitis 2Health News:Chamberlain Group Surgical Training Model Facilitates New Treatment for Chronic Rhinosinusitis 3Health News:Innophos Holdings, Inc. Declares Quarterly Dividend 2Health News:Lung cancer: Molecular scissors determine therapy effectiveness 2Health News:Drug Information Association (DIA)and Food and Drug Administration (FDA) to Host 3rd Annual Statistics Forum 2Health News:John Hancock #1 in Long-Term Care Insurance Industry Sales in 2008 2Health News:John Hancock #1 in Long-Term Care Insurance Industry Sales in 2008 3Health News:$1 Can Make The Difference 2
(Date:3/4/2015)... AUSTIN, Texas , March 4, 2015 /PRNewswire/ ... Phase II pilot study in patients with moderate ... JAMA Dermatology. The open-label Phase II trial evaluated ... Human™ monoclonal antibody that targets interleukin-1 alpha (IL-1a). ... and inflammatory cells present in skin lesions. The ...
(Date:3/4/2015)... , March 4, 2015 UPM Pharmaceuticals, a ... agreement with Sprout Pharmaceuticals to manufacture Flibanserin 100 mg ... to be the first drug approved to treat hypoactive ... female sexual dysfunction. The tablets will be ... Bristol, Tennessee . Dr. ...
(Date:3/4/2015)... March 4, 2015   Mayo Clinic and ... develop the next generation of wearable biosensors designed to ... that this technology will be game-changer. These patch biosensors ... James Levine, M.D., Ph.D. , a Mayo Clinic ... inexpensive, and can be integrated into the care people ...
Breaking Medicine Technology:XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 2UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 3Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3
MONOJECT SUPRA/HONE Blood Collection Needles - Thin Wall...
... VACUETTE Blood Collection Needles are preominantly used ... for single-use. The colour of the needle ... individual needle gauges. For example, yellow symbolises ... green 21 G (0.80 mm) and black ...
ScanGel® Centrifuge...
BIOVUE cassettes may be used manually, with a workstation consisting of a centrifuge, incubator, precision pipettes and work rack....
Medicine Products: